Inhalation Asia 2019

13 – 15 November, 2019 | Hong Kong

Proveris will showcase our latest test instruments and services for Orally Inhaled and Nasal Drug Products (OINDPs). We’ll introduce INVIDA™, a new in vitro Inhaled Drug Analysis Platform for predicting clinical performance and in vitro – in vivo correlation.

During the Podium Presentation Session Field Application Scientist, Linda (Lingzhi) Liao, will share her expertise in a presentation entitled “Critical Quality Attributes Comparison between SMIs and pMDIs.”

Please email us at contactus@proveris.com if you would like to arrange a meeting with Linda Liao during the conference, or to request additional information.

Inhalation Asia is a leading open access conference and networking event for Inhalation Drug Delivery Specialists in Asia. It is organized in partnership and hosted by the Chinese University of Hong Kong (CUHK Pharmacy).

Drug Delivery to the Lungs 2019

11 – 13 December 2019 | Edinburgh, Scotland

At Exhibit Stand #256, Proveris will showcase our latest test instruments and services for Orally Inhaled and Nasal Drug Products (OINDPs). We’ll introduce INVIDA™, a new in vitro Inhaled Drug Analysis Platform for predicting clinical performance and in vitro – in vivo correlation.

During the Scientific Poster Session, European Sales Director, Dr. Deborah Jones will present a poster entitled “A Novel Characterization of Emitted Aerosol Velocity Profiles from Metered Dose and Soft Mist Inhalers (pMDI and SMI),” authored by Linda (Lingzhi) Liao, Karina Ramos and Dino Farina.

Please email us at contactus@proveris.com if you would like to arrange a meeting with Ben Okorodudu, VP Sales, or Deborah Jones, Director of Sales during the conference, or to request information.

DDL provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.

Nasal Drug Delivery Management Forum

11 – 12 April 2019 | London, UK

Proveris’s European Sales Director, Dr. Deborah Jones, will be attending both days of the Nasal Drug Delivery Conference. If you would like to arrange a meeting with her, please email us at contactus@proveris.com.

The Nasal Drug Delivery Conference gives a comprehensive review within the field of nasal drug delivery while reviewing the very latest new data and innovative technologies.

The 8th Medicon Valley Inhalation Symposium

9 – 10 October 2019 | Lund, Sweden

Proveris’s European Sales Director, Dr. Deborah Jones, will be attending the conference. If you would like to arrange a meeting with her, please email us at contactus@proveris.com.

Medicon Valley Inhalation Symposium organized focuses on the future opportunities in inhalation and provides the attendees with the opportunity to explore various aspects relating to the topic of inhalation.

InspireMe Dry Powder and Soft Mist Inhaler Technology Forum

4 – 5 June 2019 | San Francisco, California, USA

Proveris’s Senior Application Chemist, Heli Chauhan, will present at the upcoming InspireMe Technology Forum in San Francisco. The DPI presentation will discuss new approaches for IVIVC. The soft mist presentation will review the critical quality attributes (CQAs) for soft mist, according to the newest FDA guidance documents. Both presentations will provide insights from product characterization, performance, safety and bioequivalence testing conducted by Proveris Laboratories.

At the booth, you’ll have an opportunity to meet with VP of Sales, Ben Okorodudu, to learn about Proveris’s portfolio of analytical instruments and laboratory services. If you would like to arrange a meeting in advance of the conference, please email us at: contactus@proveris.com.

InspireMe Technology Forum aims to inspire new ideas in the development, manufacture, and regulatory approval of DPI and Soft Mist Inhalers. The event provides attendees and sponsors the opportunity to meet with industrialists, academics, and suppliers in the DPI and Soft Mist Inhaler arena.

Inhalation Drug Delivery Systems

28 – 29 May 2019 | Boston Massachusetts, USA

Proveris’s Founder and CEO, Dino Farina, will present on the topic, “Best Practices for Establishing and Controlling a Robust Method for Inhalation Drug Product In Vitro Testing.” The presentation will review current FDA recommended guidelines for release testing of inhalation drug products and review the importance of incorporating patient usage factors into test protocols. In addition, it will offer best practices for establishing human-realistic shaking and actuation test parameters, and describe how dynamic measurements can be used for troubleshooting out-of-specification results during inhaler manufacturing and quality control.

Please email us at contactus@proveris.com if you would like to arrange a meeting with Mr. Farina.

Inhalation Drug Delivery Systems is a conference organized by PharmaEd Resources, Inc. which facilitates knowledge exchange between commercial, academic and regulatory institutions to advance quality, safety and regulatory compliance for inhalation drug delivery systems.

RDD Europe 2019

7 – 10 May 2019 | Lisbon Portugal

At Exhibit Stand #63, we’ll introduce a test service utilizing an innovative in vitro characterization technology that accurately measures the aerosolization, regional deposition, and bioavailability of inhaled drugs under human-realistic breathing profiles.

Proveris Scientific’s European Sales Director, Dr. Deborah Jones, will host an interactive workshop entitled “Control Strategy for pMDI Development and Release Testing: Factors that Impact pMDI Performance” on Wednesday May 8th at the conference.

Please email us at contactus@proveris.com if you would like to arrange a meeting with Ben Okorodudu, VP Sales, or Deborah Jones, Director of Sales during the conference, or to request information.

Respiratory Drug Delivery (RDD®) is a series of academically organized, international symposia focusing on the development and commercialization of pulmonary and nasal pharmaceutical products.

Inhalation Drug Delivery Association Conference

19-20 April, 2019 | Beijing China       

Proveris’s Field Application Scientist, Linda (Lingzhi) Liao and Local Sales Agent, Ruty Li will be attending the Inhalation Drug Delivery Association Conference, April 19-20, 2019 in Hangzhou China.

Please email us at contactus@proveris.com if you would like to arrange a meeting with them during the symposium, or to request additional information.

Organized by the National Inhalation Drug Delivery Alliance the conference focus is on “inhalation of generic consistency assessment and bioequivalence studies.” Members of the alliance include a experts and scholars with rich experience in inhaled drug research and development, production and clinical application in drug research and development and production enterprises, colleges and universities, hospitals and other related units.

3rd Inhalation China Symposium

6 – 7 May 2019 | Hangzhou China

Proveris’s Field Application Scientist, Linda (Lingzhi) Liao, will share her expertise in a presentation entitled “How to Optimize the In Vitro Characterization of Aerosols and Nasal Sprays” at the Inhalation China Symposium, on May 7th in Hangzhou China.

Please email us at contactus@proveris.com if you would like to arrange a meeting with Linda Liao during the symposium, or to request information.

Inhalation China Symposium brings together industry professionals from China and overseas to share their thoughts, analyze and discuss the problems of inhalation technology and the future of inhalation.